1Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of typediabetes mellitus. Diabetclogia 2001,44:929- 945.
2Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insuin resistance, in the pathogenesis of type 2 diabetes mellituts. J Clin Invest 1999; 104:787- 794.
3Polonsky K, Sturis J, Bell GI, et al. Seminar in medicine of the beth Israel Hospital, Boston: Non - insulin - dependent daibetes mellitus - A genetically programmed failure of the Beta cell to compensate for insulin resistance. N Engl J Med 1996; 334(12):777 -783.
4Vauhkonen I, Niskanen L, Vanninen E, et al. Defect in insulin secretion and insulin action in non - insulin - dependent diabetes mellitus are inherited: Metabolic studies on offspring of diabetic probands.J Clin lnverst 1998;101(1):86-96.
5Kahn - SE. The importance of the beta - cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000 ; 17 (Suppl108) :2S- 8S.
7Prote D, Kahn SE.β - cell dysfunction and failure in type dibetes, potential mechanisms. Diabetes 2001 ;50(suppl 1 ) : s160- 163.
8UK Prospective Diabetes Study(UKPDS) Group: Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33). Lancet 1998; 352:837 -853.
9Tuomilehto J, Lindstrom, J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343- 1350.
10Chiasson JL, Gomis R, Hanefeld M, et al: for the Stop NIDDM tril research group. Acarbose for prevention of type 2 daibetes mellitus: The STOP - NIDDM randomized trial. The Lancet 2002;359:2072 - 2077.
